Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-17 · accession 0001567619-21-022406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-21 | 2021-12-17 | RVMD | Anders Jack | See Remarks | S - Sale | $24.41 | -170 | 8,434 | -2% | -$4,150 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-17 | S | D | 170 | $24.41 | 8,434 | D | — | — | (F3) Includes 6,013 RSUs. (F2) Includes 412 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2021. |